ACPU
Arrowgrass Capital Partners (US)’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-196,478
| Closed | -$16.8M | – | 110 |
|
|
2019
Q2 | $16.8M | Sell |
196,478
-61,900
| -24% | -$5.3M | 0.4% | 51 |
|
|
2019
Q1 | $23M | Sell |
258,378
-90,600
| -26% | -$8.05M | 0.68% | 19 |
|
|
2018
Q4 | $29.7M | Buy |
348,978
+16,443
| +5% | +$1.4M | 1.1% | 11 |
|
|
2018
Q3 | $32.2M | Sell |
332,535
-11,206
| -3% | -$1.09M | 0.99% | 18 |
|
|
2018
Q2 | $32.4M | Buy |
343,741
+97,733
| +40% | +$9.21M | 1.11% | 21 |
|
|
2018
Q1 | $19.9M | Buy |
246,008
+9,166
| +4% | +$743K | 0.68% | 33 |
|
|
2017
Q4 | $21.1M | Buy |
236,842
+5,334
| +2% | +$476K | 0.2% | 39 |
|
|
2017
Q3 | $21.5M | Buy |
231,508
+42,139
| +22% | +$3.92M | 0.16% | 62 |
|
|
2017
Q2 | $17.2M | Buy |
189,369
+15,015
| +9% | +$1.36M | 0.13% | 82 |
|
|
2017
Q1 | $15.3M | Sell |
174,354
-3,991
| -2% | -$350K | 0.16% | 77 |
|
|
2016
Q4 | $14.8M | Buy |
178,345
+123,653
| +226% | +$10.2M | 0.17% | 53 |
|
|
2016
Q3 | $5.06M | Buy |
54,692
+5,742
| +12% | +$531K | 0.07% | 99 |
|
|
2016
Q2 | $3.81M | Buy |
+48,950
| New | +$3.81M | 0.04% | 103 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 255 |
|
|
2015
Q1 | – | Sell |
-281,676
| Closed | -$25.5M | – | 222 |
|
|
2014
Q4 | $25.5M | Buy |
281,676
+84,102
| +43% | +$7.6M | 0.45% | 25 |
|
|
2014
Q3 | $14.3M | Buy |
197,574
+48,353
| +32% | +$3.49M | 0.35% | 35 |
|
|
2014
Q2 | $9.28M | Buy |
149,221
+68,914
| +86% | +$4.29M | 0.27% | 64 |
|
|
2014
Q1 | $5.48M | Buy |
+80,307
| New | +$5.48M | 0.22% | 89 |
|
|
2013
Q4 | – | Sell |
-475,980
| Closed | -$34.4M | – | 130 |
|
|
2013
Q3 | $34.4M | Buy |
+475,980
| New | +$34.4M | 1.29% | 13 |
|